We analyzed tumor and infectious disease antigen-specific CD8+ T-cell immune monitoring, FoxP3 mRNA quantitation, and T-cell activation/memory marker surface staining concurrently to detect trends relating to clinical parameters. This evidence concerns the gene CD8A and infectious disease.